Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1982-06-07
1984-10-23
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
A61K 4904
Patent
active
044788169
ABSTRACT:
A rare earth/chelating agent complex is employed in digital fluoroscopy. More specifically, a contrast medium is utilized in digital fluoroscopy, the contrast medium consisting of a non-radioactive composition of a rare earth metal and a chelating agent. The rare earth metal is lutecium or ytterbium, while the chelating agent is DTPA, EHPG or HBED. The digital fluoroscopy method results in the development of diagnostic energy difference image information as a result of application of X-ray beams of two different energy levels, coupled with subtraction processing of the resulting image information.
REFERENCES:
patent: 3480715 (1969-11-01), Catsch
patent: 3663688 (1972-05-01), Grotenhuis
patent: 3995020 (1976-11-01), Dandamudi
patent: 4017596 (1977-04-01), Loberg et al.
patent: 4176173 (1979-11-01), Winchell et al.
patent: 4192859 (1980-03-01), Mackaness et al.
patent: 4283382 (1981-08-01), Frank et al.
patent: 4310507 (1982-01-01), Luckey
Ledley Robert S.
Zapolski Edward J.
Georgetown University
Waddell Frederick E.
LandOfFree
Rare earth/chelating agent complex for digital fluoroscopy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rare earth/chelating agent complex for digital fluoroscopy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rare earth/chelating agent complex for digital fluoroscopy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1598597